Pharmaceutical News

RSS

Research reveals administration of ineffective COVID-19 treatments after FDA deauthorization

Monoclonal antibodies are laboratory-designed treatments tailor-made to fight specific infections. In early 2021, the U.S. Food & Drug Administration issued emergency use authorization for two monoclonal antibodies (bamlanivimab/etesevimab and casirivimab/imdevimab) for the treatment of mild to moderate COVID-19 in high-risk, non-hospitalized patients.

30 Aug 2022

mRNA COVID boosters are effective against severe Omicron for at least six months

A new study published in the journal JAMA Network Open aimed to analyze the association of the types of vaccine and their combination with the waning of protection against Omicron in residents of Singapore who were aged 30 years and above and had received at least two doses of a COVID vaccine.

30 Aug 2022

Full-dose anticoagulation lowers the risk of blood clotting complications in COVID-19 patients

A clinical trial of patients with COVID-19 led by investigators at the TIMI Study Group at Brigham and Women's Hospital and the Critical Care Cardiology Trials Network has found that full-dose anticoagulation lowers the risk of blood clotting complications compared with standard-dose prophylactic anticoagulation.

29 Aug 2022

TTUHSC scientist receives U.S. patent to produce novel nanoantibiotics

According to the Centers for Disease Control and Prevention, more than 2.8 million Americans contract antibiotic-resistant bacterial infections each year, and approximately 35,000 of those patients do not survive their infection.

29 Aug 2022

Study compares the benefits of taking antihypertensive medication in the morning or evening

A pragmatic randomised trial in more than 21,000 patients with high blood pressure followed for over five years has concluded that protection against heart attack, stroke and vascular death is not affected by whether antihypertensive medications are taken in the morning or evening.

26 Aug 2022

The risk of adverse reactions when herbal medications are taken with cancer drugs

A new study discusses phytovigilance initiatives based on the real-world use of herbal drugs in cancer along with conventional chemotherapy.

24 Aug 2022

Glucokinase activator AZD1656 shows potential benefit for diabetics with moderate to severe COVID-19

A new study examines the potential benefit of the glucokinase activator molecule AZD1656 in the ARCADIA trial.

23 Aug 2022

Updated guidelines on the Valneva SARS-CoV-2 vaccine

The WHO provides interim guidelines for the use of the Valneva vaccine.

23 Aug 2022

Medical marijuana users more likely to also use nicotine products

People who use therapeutic cannabis are more likely to also use nicotine products than the general population, according to a Rutgers study.

23 Aug 2022

Direct acting antiviral medications for hepatitis C may improve PTSD symptoms

More than six percent of Americans will develop posttraumatic stress disorder (PTSD) in their lifetime. This potentially chronic condition disrupts lives, and can lead to or exacerbate existing health issues such as depression, anxiety, eating disorders, and suicidal thoughts.

22 Aug 2022

Medical cannabis patients may not be getting consistent guidance from clinicians, analysis suggests

Due to a lack of publicly available data, understanding what products medical cannabis patients use for various conditions has mostly come from survey responses.

22 Aug 2022

Study finds a declining trend in use of medications for sleep disturbance among Americans

Americans aren't turning to pharmaceutical options as often in the never-ending battle for a good night's sleep.

16 Aug 2022

Financial incentives from pharma companies can influence how vision care practitioners prescribe branded eyedrops

In a lookback study of prescribing patterns among thousands of American ophthalmologists and optometrists, Johns Hopkins Medicine researchers concluded that eye doctors who receive even small financial incentives from pharmaceutical companies, such as free food, sponsored travel to attend meetings or consulting fees, are up to twice as likely to prescribe the companies' brand name eyedrops for glaucoma instead of cheaper generic versions.

15 Aug 2022

ACR appreciates the passage of key drug pricing reforms in the Inflation Reduction Act

Previous
1
...
70
71
72
73
74
75
76
...
1434
Next

Pharmaceutical News

Research reveals administration of ineffective COVID-19 treatments after FDA deauthorization

mRNA COVID boosters are effective against severe Omicron for at least six months

Full-dose anticoagulation lowers the risk of blood clotting complications in COVID-19 patients

TTUHSC scientist receives U.S. patent to produce novel nanoantibiotics

Study compares the benefits of taking antihypertensive medication in the morning or evening

The risk of adverse reactions when herbal medications are taken with cancer drugs

Glucokinase activator AZD1656 shows potential benefit for diabetics with moderate to severe COVID-19

Updated guidelines on the Valneva SARS-CoV-2 vaccine

Medical marijuana users more likely to also use nicotine products

Direct acting antiviral medications for hepatitis C may improve PTSD symptoms

Medical cannabis patients may not be getting consistent guidance from clinicians, analysis suggests

Study finds a declining trend in use of medications for sleep disturbance among Americans

Financial incentives from pharma companies can influence how vision care practitioners prescribe branded eyedrops

ACR appreciates the passage of key drug pricing reforms in the Inflation Reduction Act

Superior protection with 'mix-and-match' COVID-19 booster strategy

In monkeys, spike-based vaccines produce some immunity based on CD8 T-cells

Scientists create a mathematical model to predict genetic resistance to antimalarial drugs

Big pharma went all in to kill drug pricing negotiations

Experts urge FDA to include T cell responses when evaluating COVID vaccines

Vaccines and monoclonal antibodies being developed for respiratory syncytial virus

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News